Li-Ming Zhang

Li-Ming Zhang

Auto-generated profile, based on publicly available information

Li-Ming Zhang

Hunan University of Medicine, Huaihua, Hunan, 410208, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2010 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
LZLiming Zhang
Liming Zhang
TDTan Deng
Tan Deng
XLXiayu Li
Xiayu Li
HLHuaying Liu
Huaying Liu
ZHZhou Hou-De
Zhou Hou-De
GLGuiyuan Li
Guiyuan Li
MicroRNAs (miRNAs) are small non-coding RNAs and have been implicated in the pathology of various diseases, including cancer. Here we report that the miRNA profiles have been changed after knockdown of one of the most important oncogene c-MYC or re-expression of a candidate tumor suppressor gene SPLUNC1 in nasopharyngeal carcinoma (NPC) cells. Both c-MYC knockdown and SPLUNC1 re-expression can down-regulate microRNA-141 (miR-141). miR-141 is up-regulated in NPC specimens in comparison with normal nasopharyngeal epithelium. Inhibition of miR-141 could affect cell cycle, apoptosis, cell growth, migration and invasion in NPC cells. We found that BRD3 , UBAP1 and PTEN are potential targets of miR-141, which had been confirmed following luciferase reporter assays and western blotting. BRD3 and UBAP1 are both involved in NPC carcinogenesis as confirmed through our previous studies and PTEN is a crucial tumor suppressor in many tumor types. BRD3 is involved in the regulation of the Rb/E2F pathway. Inhibition of miR-141 could affect some important molecules in the Rb/E2F, JNK2 and AKT pathways. It is well known that carcinogenesis of NPC is involved in the networks of genetic and epigenetic alteration events. We propose that miR-141- and tumor-related genes c-MYC , SPLUNC1 , BRD3 , UBAP1 and PTEN may constitute a gene–miRNA network to contribute to NPC development.

1 May 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
LZLi-Ming Zhang
Li-Ming Zhang
JZJun Zhang
Jun Zhang
YZYing Zhang
Ying Zhang
CFChang Fei
Chang Fei
LWLin Wang
Lin Wang
ZZZai-Qi Zhang
Zai-Qi Zhang
Idiopathic pulmonary fibrosis (IPF) is a lethal disease of unknown aetiology that largely presents in the elderly. The mechanisms related to aging such as fibroblast senescence have been strongly implicated in pathology of IPF. We have previously demonstrated the protective effects of IL-18 binding protein (IL-18BP) against bleomycin (BLM)-induced pulmonary fibrosis (PF) via inhibition of epithelial-to-mesenchymal transition. However, the role of IL-18 in fibroblast senescence in PF is still unknown. The aim of this study was to investigate the effects of IL-18 on fibroblast senescence in the development of PF. We found that SA-β-gal positive cells, the proportion of cells in G1 phase, and expressions of p21 and p53 were increased in primary lung fibroblasts isolated from BLM-challenged mice, while the fibroblasts from IL-18BP-treated mice showed decreased senescence propensity. We further demonstrated that IL-18 was sufficient to trigger senescence of primary lung fibroblasts. The senescence-associated secretory phenotype (SASP) of fibroblasts treated with IL-18 robustly stimulated a fibrotic phenotype in pulmonary fibroblasts. Moreover, the expression of Klotho, an anti-senescence protein, was down-regulated after IL-18 treatment in primary lung fibroblasts. Overexpression of Klotho reversed the senescence and SASP induced by IL-18 in lung fibroblasts. In summary, we reported for the first time that IL-18 promoted the lung fibroblast senescence and SASP in PF through blocking Klotho pathway. Neutralize IL-18 by IL-18BP exhibited antifibrotic effects partly by suppressing lung fibroblast senescence in PF. It contributes to the growing evidence that IL-18 could be a therapeutic target for PF.

1 January 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LZLi-Ming Zhang
Li-Ming Zhang
YZYing Zhang
Ying Zhang
CFChang Fei
Chang Fei
JZJun Zhang
Jun Zhang
LWLin Wang
Lin Wang
GGGe Gao
Ge Gao

27 November 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
SYShuqiao Yang
Shuqiao Yang
DCDandan Chai
Dandan Chai
YLYihua Li
Yihua Li
YWYuanying Wang
Yuanying Wang
XZXi Zhan
Xi Zhan
QYQiao Ye
Qiao Ye